Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "SEC"

2359 News Found

Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma
Diagnostic Center | June 05, 2023

Keytruda+ chemotherapy improves overall survival versus chemotherapy alone for unresectable advanced pleural mesothelioma

In Phase 3 CCTG IND.227/KEYNOTE-483 trial, KEYTRUDA plus chemotherapy also demonstrated statistically significant improvements in PFS and ORR compared to chemotherapy alone


Health Minister Mandaviya inaugurates 8th International Conference on Pharma and Medical Device Sector
Policy | May 27, 2023

Health Minister Mandaviya inaugurates 8th International Conference on Pharma and Medical Device Sector

Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector


Venus Remedies secures marketing authorization from UK MHRA for Cisplatin
News | April 27, 2023

Venus Remedies secures marketing authorization from UK MHRA for Cisplatin

Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country


Ministry of Ayush ensures the benchmarking of AI in traditional medicine, says Ayush Secretary
Digitisation | April 19, 2023

Ministry of Ayush ensures the benchmarking of AI in traditional medicine, says Ayush Secretary

Ministry of Ayush is leading a topic group on traditional medicine as part of Focus Group on Artificial Intelligence for Health (FG-AI4H)


India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting
Policy | April 05, 2023

India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting

Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted


HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
Biotech | April 01, 2023

HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData

SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development


ART and Surrogacy Bill strives to provide patients with better medical care and security: Dr. Mandaviya
News | February 06, 2023

ART and Surrogacy Bill strives to provide patients with better medical care and security: Dr. Mandaviya

With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India


Economic Survey 2022-23: Industry sector witness growth of 4.1%
Policy | February 01, 2023

Economic Survey 2022-23: Industry sector witness growth of 4.1%

The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021


Aurobindo's subsidiary Tergene Biotech receives SEC recommendation for pneumococcal 15 valent vaccine
Drug Approval | December 28, 2022

Aurobindo's subsidiary Tergene Biotech receives SEC recommendation for pneumococcal 15 valent vaccine

The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come